XIAFLEX: payments to doctors
Payments that named XIAFLEX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $10.1M
- Providers
- 15,961
- Transactions
- 96,601
- Average per transaction
- $105
The per-transaction average — $105 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 15,961 providers the average total is $633, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Endo Pharmaceuticals Inc. | $7,361,703 | 72.8% |
| Endo USA, Inc. | $2,745,469 | 27.2% |